Catalyst Wire Dossier Catalyst Wire Dossier

Tempol

4-hydroxy-TEMPO · Matrix Biomed, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tempol, covering 2008-12-03 to 2024-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Radiation and Cisplatin Induced Toxicities with Tempol [Phase 2]

See pricing